[{"Assets_0_Q1_USD":1756536000.0,"CommonStockSharesOutstanding_0_Q1_shares":156885028.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":22212000.0,"NetIncomeLoss_1_Q1_USD":-96398000.0,"StockholdersEquity_0_Q1_USD":1102141000.0,"Ticker":"ALKS","CIK":"1520262","name":"ALKERMES PLC.","OfficialName":"Alkermes plc Ordinary Shares","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4612884468.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190425"}]